We are live on ! Find out more
SHC icon

Sotera Health

18.37 USD
+0.11
0.6%
At close Updated Sep 11, 4:00 PM EDT
Pre-market
After hours
18.37
0.00
0%
1 day
0.6%
5 days
-2.86%
1 month
-3.87%
3 months
12.08%
6 months
31.97%
Year to date
3.84%
1 year
13.96%
5 years
-26.28%
10 years
-26.81%
 

About: Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.

Employees: 3,000

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 28.6%
Neutral 71.4%
Negative 0%
Neutral
Seeking Alpha
2 days ago
Sotera Health Company (SHC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Sotera Health Company (SHC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Sotera Health Company (SHC) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Neutral
MarketBeat
1 month ago
Sotera Health Q2 Earnings Call Highlights
Sotera Health NASDAQ: SHC reported second-quarter 2026 results that included 8% constant-currency revenue growth, higher adjusted EBITDA margins and an increase to its full-year revenue and adjusted EBITDA outlook.
Sotera Health Q2 Earnings Call Highlights
Neutral
Seeking Alpha
1 month ago
Sotera Health Company (SHC) Q2 2026 Earnings Call Transcript
Sotera Health Company (SHC) Q2 2026 Earnings Call Transcript
Sotera Health Company (SHC) Q2 2026 Earnings Call Transcript
Positive
Zacks Investment Research
1 month ago
Sotera Health (SHC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Sotera Health (SHC) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Sotera Health (SHC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Positive
Zacks Investment Research
1 month ago
Sotera Health Company (SHC) Beats Q2 Earnings and Revenue Estimates
Sotera Health Company (SHC) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.2 per share a year ago.
Sotera Health Company (SHC) Beats Q2 Earnings and Revenue Estimates
Neutral
GlobeNewsWire
1 month ago
Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook
Q2 2026 net revenues increased 9.2% or 8.0% on a constant currency basis (1) compared to Q2 2025 Q2 2026 net income of $54 million or $0.19 per diluted share, compared to net income of $8 million or $0.03 per diluted share in Q2 2025 Q2 2026 Adjusted EBITDA ( 1 ) increased 10.0%, or 8.7% on a constant currency basis Q2 2026 Adjusted EPS (1) of $0.26, an increase of 30% per diluted share Company raises both full-year 2026 net revenues growth out look to 5.25% - 6.75% and Adjusted EBITDA growth outlook to 5.75% - 7.25%, on a constant currency basis CLEVELAND, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three- and six- months ended June 30, 2026. “We delivered another strong quarter, with high-single-digit growth, reflecting focused execution across all three of our business units,” said Chief Executive Officer Alton Shader.
Sotera Health Delivers Strong Second-Quarter and First-Half 2026 Results and Raises FY 2026 Outlook
Neutral
GlobeNewsWire
1 month ago
Sotera Health Announces Second-Quarter 2026 Earnings Release Date
CLEVELAND, July 23, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the second-quarter ended June 30, 2026 before the market opens on Thursday, August 6, 2026. Following the release, management will host a conference call at 9:00 a.m.
Sotera Health Announces Second-Quarter 2026 Earnings Release Date
Neutral
Seeking Alpha
3 months ago
Sotera Health Company (SHC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Sotera Health Company (SHC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Sotera Health Company (SHC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Neutral
Seeking Alpha
3 months ago
Sotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Sotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Sotera Health Company (SHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Neutral
Seeking Alpha
3 months ago
Sotera Health Company (SHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
Sotera Health Company (SHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
Sotera Health Company (SHC) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
Price charts implemented using Lightweight Charts™